阿卡迪亚

ACAD NASDAQ
25.42
+1.16
+4.78%
已收盘, 17:56 06/17 EDT
开盘
24.62
昨收
24.26
最高
25.62
最低
24.38
成交量
147.99万
成交均量(3M)
106.50万
52周最高
28.67
52周最低
12.77
换手率
1.03%
市值
36.65亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供阿卡迪亚 ACAD股票价格,阿卡迪亚股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis). NUPLAZID is a selective serotonin inverse agonist (SSIA), preferentially targeting 5-HT2A receptors. The Company is conducting a Phase II trial, referred to as the SERENE Study, designed to examine the efficacy and safety of pimavanserin as a treatment for Alzheimer's disease (AD) Agitation. It is also conducting a Phase III, six-week, randomized, double-blind, placebo-controlled, multi-center, outpatient study, referred to as the ENHANCE-1 study, designed to examine the use of pimavanserin in patients with schizophrenia.
展开 >

最近浏览

名称
价格
涨跌幅